CRBN mediates immunomodulatory drug (IMiD)-induced death of multiple myeloma cells by promoting the ubiquitination-mediated degradation of two transcription factors IKZF1 and IKZF326,27. The gene discussed is CRBN; the disease is plasma cell myeloma.